-$0.08 Earnings Per Share Expected for Christopher & Banks (CBK) This Quarter

Wall Street analysts expect Christopher & Banks (NYSE:CBK) to post earnings per share (EPS) of ($0.08) for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for Christopher & Banks’ earnings. Christopher & Banks reported earnings per share of ($0.10) during the same quarter last year, which would suggest a positive year over year growth rate of 20%. The company is scheduled to announce its next quarterly earnings results on Thursday, May 24th.

According to Zacks, analysts expect that Christopher & Banks will report full-year earnings of ($0.21) per share for the current fiscal year. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Christopher & Banks.

How to Become a New Pot Stock Millionaire

Christopher & Banks (NYSE:CBK) last announced its quarterly earnings data on Thursday, March 8th. The specialty retailer reported ($0.23) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.27) by $0.04. Christopher & Banks had a negative net margin of 6.02% and a negative return on equity of 35.95%. The company had revenue of $92.27 million during the quarter. During the same period in the prior year, the firm earned ($0.46) earnings per share.

Several analysts have recently issued reports on CBK shares. Zacks Investment Research raised shares of Christopher & Banks from a “strong sell” rating to a “hold” rating in a research note on Friday, February 2nd. ValuEngine raised shares of Christopher & Banks from a “strong sell” rating to a “sell” rating in a research report on Monday, April 2nd.

An institutional investor recently raised its position in Christopher & Banks stock. Northern Trust Corp increased its holdings in shares of Christopher & Banks (NYSE:CBK) by 1.5% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 106,505 shares of the specialty retailer’s stock after purchasing an additional 1,619 shares during the period. Northern Trust Corp owned 0.28% of Christopher & Banks worth $140,000 as of its most recent filing with the Securities and Exchange Commission. 38.86% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NYSE CBK opened at $1.11 on Wednesday. Christopher & Banks has a 52-week low of $0.95 and a 52-week high of $1.55.

TRADEMARK VIOLATION NOTICE: This piece was first reported by Ticker Report and is the property of of Ticker Report. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece can be read at https://www.tickerreport.com/banking-finance/3337964/0-08-earnings-per-share-expected-for-christopher-banks-cbk-this-quarter.html.

Christopher & Banks Company Profile

Christopher & Banks Corporation, through its subsidiaries, operates as a specialty retailer of private-brand women's apparel and accessories in the United States. The company designs and sells women's apparel and accessories to customers ranging in age from 40 and older. Its stores offer women's apparel consisting of casual clothing, everyday basics, wear-to-work, leisure/active wear, and sleepwear in missy, petite, and women sizes, as well as jewelry and accessories.

Get a free copy of the Zacks research report on Christopher & Banks (CBK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Christopher & Banks (NYSE:CBK)

Receive News & Ratings for Christopher & Banks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Christopher & Banks and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Havven  Price Up 28% Over Last 7 Days
Havven Price Up 28% Over Last 7 Days
Head to Head Survey: Roper Technologies  & Mesa Laboratories
Head to Head Survey: Roper Technologies & Mesa Laboratories
Comparing PCM  & The Competition
Comparing PCM & The Competition
Brokerages Set $41.00 Price Target for Hutchison China MediTech Limited
Brokerages Set $41.00 Price Target for Hutchison China MediTech Limited
Logitech  Expected to Post Earnings of $0.26 Per Share
Logitech Expected to Post Earnings of $0.26 Per Share
Perrigo  Given a $105.00 Price Target by Canaccord Genuity Analysts
Perrigo Given a $105.00 Price Target by Canaccord Genuity Analysts


© 2006-2018 Ticker Report. Google+.